Urinary exosomes: a promising biomarker of drug-induced nephrotoxicity

Zunzhen Zhou1, Dailiang Zhang1, Yongjing Wang1

  • 1Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.

Frontiers in Medicine
|October 9, 2023
PubMed

Insights

Urinary exosomes show promise as early biomarkers for drug-induced nephrotoxicity (DIN). Research highlights their potential for accurate detection of renal injury, improving patient outcomes.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Drug Safety

Background:

  • Drug-induced nephrotoxicity (DIN) poses a significant clinical challenge, with current detection methods lacking accuracy for early renal injury.
  • The inevitable use of nephrotoxic drugs necessitates improved diagnostic tools for timely intervention.
  • Urinary exosomes are emerging as a promising source for identifying kidney disease biomarkers.

Purpose of the Study:

  • To explore the potential of urinary exosomes as biomarkers for early detection of drug-induced nephrotoxicity (DIN).
  • To review the mechanisms of DIN and the biogenesis of urinary exosomes.
  • To discuss the utility of urinary exosome changes in predicting DIN and compare them with existing indicators.

Main Methods:

  • Literature review on DIN pathogenesis and urinary exosome biogenesis.
  • Analysis of studies investigating urinary exosome alterations in drug-induced nephrotoxicity.
  • Comparative assessment of urinary exosomes against other predictive biomarkers for DIN.

Main Results:

  • Urinary exosomes offer a non-invasive approach for monitoring kidney health.
  • Specific changes in urinary exosomes correlate with the onset of drug-induced kidney damage.
  • Exosomal biomarkers demonstrate potential for earlier and more accurate DIN detection.

Conclusions:

  • Urinary exosomes represent a valuable resource for developing novel biomarkers for drug-induced nephrotoxicity.
  • Further research into exosomal content and function can enhance early diagnosis and management of DIN.
  • Harnessing urinary exosome potential can significantly improve patient safety in clinical medication.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
197
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
170
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
202
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
105